Drug intelligence / Profile preview

ASI-02

Development stage
Phase 3
Lead developer
Agitated Solutions
Modality
Acoustic/Optical: Sonoporation, laser photoporation → Physical Methods → Gene Addition/Replacement → Gene Therapies
Administration
Intravenous
01

Overview

ASI-02 is a standardized agitated saline contrast agent developed by Agitated Solutions for use in transthoracic echocardiography (TTE) to detect right-to-left shunts, such as patent foramen ovale (PFO). Unlike traditional manual agitation, which is highly variable and operator-dependent, ASI-02 is produced using a proprietary automated agitation device (the Orbis system) to create a consistent concentration and size distribution of microbubbles. These microbubbles serve as an ultrasound contrast medium; when injected intravenously, they are normally filtered by the lungs, but their appearance in the left heart chambers indicates the presence of a shunt. The agent is currently being evaluated in Phase 3 clinical trials to demonstrate superior sensitivity and reproducibility compared to standard-of-care manual agitated saline.

Other names
automated agitated salinestandardized agitated saline

Beyond the preview

Go deeper on ASI-02.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASI-02.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call